Clinical characteristics of infants requiring level 2 neonatal care (SCN) for hypoglycaemia
| GCP | FCP | P value | |
| No of admissions to SCN (% among infants screened) | 246 (16.8%) | 102 (3.4%) | 0.000 |
| Sex (male, %) | 139 (56.5%) | 57 (55.8%) | 0.915 |
| Median gestational age (weeks) | 37.5 | 38.1 | 0.002 |
| Weight-for-age status | SGA=48 (19.5%) AGA=169 (68.7%) LGA=29 (11.8%) | SGA=24 (23.5%) AGA=61 (59.8%) LGA=17 (16.7%) | 0.256 |
| Infant of diabetic mother (% of SCN admissions) | 122 (50%) | 41 (40%) | 0.109 |
| Infants requiring buccal glucose (% of FCP infants screened) | NA | 387 (13%) | NA |
| Infants requiring IV dextrose (% of SCN admissions) | 136 (55%) | 88 (86%) | 0.000 |
| Infants requiring medications* (% of SCN admissions) | 14 (5.7%) | 4 (4%) | 0.497 |
| Total SCN days | 458 | 354 | NA |
| Mean total length of stay (days) | 2.43 | 3.49 | 0.001 |
*Medications: glucagon, hydrocortisone, diazoxide.
AGA, appropriate for gestational age; FCP, feed-centric pathway; GCP, glucose-centric pathway; IV, intravenous; LGA, large for gestational age; NA, not applicable; SCN, special care nursery; SGA, small-for-gestational-age.